Line 4: |
Line 4: |
| ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists | | ! Receptor !! Binding Affinity !! Effects !! Mechanism !! Agonists !! Antagonists |
| |- | | |- |
− | | α1 || Norepi > Epi >> Iso || Smooth muscle contraction || Gq, PLC -> IP3/DAG | + | | α1 || NE > Epi >> Iso || Smooth muscle contraction || Gq, PLC -> IP3/DAG |
| | | | | |
− | *Norepi | + | *NE |
| *Phenylephrine | | *Phenylephrine |
| *Midodrine | | *Midodrine |
Line 14: |
Line 14: |
| *Tamsulosin | | *Tamsulosin |
| |- | | |- |
− | | α2 || Epi = Norepi >> Iso || Mixed effects || Gi, presynaptic, cAMP down | + | | α2 || Epi = NE >> Iso || Mixed effects || Gi, presynaptic, cAMP down |
| | | | | |
| *Dexmedetomidine | | *Dexmedetomidine |
Line 24: |
Line 24: |
| *Trazodone | | *Trazodone |
| |- | | |- |
− | | β1 || Iso > Norepi > Epi || Chronotropy, Inotropy, Amylase secretion || Gs, cAMP up | + | | β1 || Iso > NE > Epi || Chronotropy, Inotropy, Amylase secretion || Gs, cAMP up |
| | | | | |
| *Dobutamine | | *Dobutamine |
Line 35: |
Line 35: |
| *Esmolol | | *Esmolol |
| |- | | |- |
− | | β2 || Iso > Epi > Norepi || Smooth muscle relaxation || Gs, cAMP up | + | | β2 || Iso > Epi > NE || Smooth muscle relaxation || Gs, cAMP up |
| | | | | |
| *Albuterol | | *Albuterol |
Line 52: |
Line 52: |
| *Labet'''alol''' (anti-α1) | | *Labet'''alol''' (anti-α1) |
| |- | | |- |
− | | β3 || Iso > Epi = Norepi || Lipolysis, bladder detrusor relaxation || Gs, cAMP up | + | | β3 || Iso > Epi = NE || Lipolysis, bladder detrusor relaxation || Gs, cAMP up |
| | | | | |
| *Mirabegron | | *Mirabegron |